Core Insights - The company is focusing on a "Big Push in Q4" initiative to efficiently coordinate production, supply, and sales, aiming to meet annual targets [1] - In October, the company achieved significant production efficiency and cost optimization, exceeding production plans for core products [1] - The sales strategy is adapting to market challenges by enhancing customer development and expanding sales channels, particularly in the raw materials and formulations sectors [2] - A collaborative support system is in place to ensure supply stability, cost reduction, and quality assurance, contributing to the company's confidence in achieving its annual goals [3] Production Efficiency and Cost Reduction - The production system is guided by principles of "full load, high efficiency, and low cost," implementing a "weekly scheduling and daily tracking" control mechanism [1] - Various plants have made significant progress in cost reduction and efficiency improvement through process optimization and energy management [1] - The 202 plant has achieved breakthroughs in both new project development and existing project optimization, enhancing production efficiency for key products [1] Sales Strategy and Market Expansion - The sales system is closely monitoring market trends and adjusting strategies to address intensified competition and demand fluctuations [2] - The company is actively participating in international exhibitions to expand sales channels and improve customer engagement [2] - New business initiatives, such as health food and cosmetics, are being accelerated to diversify revenue streams [2] Collaborative Support System - The support system emphasizes "strong service, supply assurance, and baseline protection," fostering cross-departmental collaboration [3] - The procurement department is ensuring stable supply through multi-channel strategies, while energy management is focused on cost reduction [3] - Quality inspection processes are strictly enforced to maintain product quality, contributing to a robust operational framework [3]
产供销高效联动 东北制药四季度开局稳中有进